153 related articles for article (PubMed ID: 22307269)
21. High throughput mass spectrometry-based mutation profiling of primary uveal melanoma.
Daniels AB; Lee JE; MacConaill LE; Palescandolo E; Van Hummelen P; Adams SM; DeAngelis MM; Hahn WC; Gragoudas ES; Harbour JW; Garraway LA; Kim IK
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6991-6. PubMed ID: 22977135
[TBL] [Abstract][Full Text] [Related]
22. Uveal melanoma driver mutations in GNAQ/11 yield numerous changes in melanocyte biology.
Perez DE; Henle AM; Amsterdam A; Hagen HR; Lees JA
Pigment Cell Melanoma Res; 2018 Sep; 31(5):604-613. PubMed ID: 29570931
[TBL] [Abstract][Full Text] [Related]
23. Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner.
Khalili JS; Yu X; Wang J; Hayes BC; Davies MA; Lizee G; Esmaeli B; Woodman SE
Clin Cancer Res; 2012 Aug; 18(16):4345-55. PubMed ID: 22733540
[TBL] [Abstract][Full Text] [Related]
24. Digital PCR validates 8q dosage as prognostic tool in uveal melanoma.
Versluis M; de Lange MJ; van Pelt SI; Ruivenkamp CA; Kroes WG; Cao J; Jager MJ; Luyten GP; van der Velden PA
PLoS One; 2015; 10(3):e0116371. PubMed ID: 25764247
[TBL] [Abstract][Full Text] [Related]
25. GNAQ
Urtatiz O; Cook C; Huang JL; Yeh I; Van Raamsdonk CD
Pigment Cell Melanoma Res; 2020 Jan; 33(1):96-111. PubMed ID: 31680437
[TBL] [Abstract][Full Text] [Related]
26. Mutation of GNAQ in a cytologically unusual choroidal melanoma in an 18-month-old child.
Levasseur SD; Paton KE; Van Raamsdonk CD; Heran MK; White VA
JAMA Ophthalmol; 2013 Jun; 131(6):810-2. PubMed ID: 23572156
[No Abstract] [Full Text] [Related]
27. Somatic Activating Mutations in GNAQ and GNA11 Are Associated with Congenital Hemangioma.
Ayturk UM; Couto JA; Hann S; Mulliken JB; Williams KL; Huang AY; Fishman SJ; Boyd TK; Kozakewich HP; Bischoff J; Greene AK; Warman ML
Am J Hum Genet; 2016 Apr; 98(4):789-95. PubMed ID: 27058448
[TBL] [Abstract][Full Text] [Related]
28. GNAS, GNAQ, and GNA11 alterations in patients with diverse cancers.
Parish AJ; Nguyen V; Goodman AM; Murugesan K; Frampton GM; Kurzrock R
Cancer; 2018 Oct; 124(20):4080-4089. PubMed ID: 30204251
[TBL] [Abstract][Full Text] [Related]
29. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.
Ewens KG; Kanetsky PA; Richards-Yutz J; Purrazzella J; Shields CL; Ganguly T; Ganguly A
Invest Ophthalmol Vis Sci; 2014 Jun; 55(8):5160-7. PubMed ID: 24970262
[TBL] [Abstract][Full Text] [Related]
30. [Circumscribed choroidal hemangioma and non-pigmented choroidal melanoma: clinical, instrumental and molecular genetic features].
Saakyan SV; Sklyarova NV; Tsygankov AY; Alikhanova VR; Loginov VI; Burdenny AM
Vestn Oftalmol; 2024; 140(2):5-13. PubMed ID: 38742493
[TBL] [Abstract][Full Text] [Related]
31. GNA11 and N-RAS mutations: alternatives for MAPK pathway activating GNAQ mutations in primary melanocytic tumours of the central nervous system.
Gessi M; Hammes J; Lauriola L; Dörner E; Kirfel J; Kristiansen G; zur Muehlen A; Denkhaus D; Waha A; Pietsch T
Neuropathol Appl Neurobiol; 2013 Jun; 39(4):417-25. PubMed ID: 22758774
[TBL] [Abstract][Full Text] [Related]
32. Frequencies of KIT and GNAQ mutations in acral melanoma.
Puntervoll HE; Molven A; Akslen LA
J Cutan Pathol; 2014 Nov; 41(11):893-4. PubMed ID: 25363280
[No Abstract] [Full Text] [Related]
33. Ultradeep sequencing detects GNAQ and GNA11 mutations in cell-free DNA from plasma of patients with uveal melanoma.
Metz CH; Scheulen M; Bornfeld N; Lohmann D; Zeschnigk M
Cancer Med; 2013 Apr; 2(2):208-15. PubMed ID: 23634288
[TBL] [Abstract][Full Text] [Related]
34. RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma.
Chen X; Wu Q; Depeille P; Chen P; Thornton S; Kalirai H; Coupland SE; Roose JP; Bastian BC
Cancer Cell; 2017 May; 31(5):685-696.e6. PubMed ID: 28486107
[TBL] [Abstract][Full Text] [Related]
35. Research in practice: Therapeutic targeting of oncogenic GNAQ mutations in uveal melanoma.
Gaffal E
J Dtsch Dermatol Ges; 2020 Nov; 18(11):1245-1248. PubMed ID: 32954611
[TBL] [Abstract][Full Text] [Related]
36. Skin metastases in metastatic uveal melanoma: GNAQ/GNA11 mutational analysis as a valuable tool.
Tsianakas A; Böhm MR; Getova V; Metze D; Eter N; Spieker T; Bräuninger A; Luger T; Schiller M; Sunderkötter C
Br J Dermatol; 2013 Jul; 169(1):160-3. PubMed ID: 23464620
[TBL] [Abstract][Full Text] [Related]
37. Intermediate-grade meningeal melanocytoma associated with nevus of Ota: a case report and review of the literature.
Shin D; Sinha M; Kondziolka DS; Kirkwood JM; Rao UN; Tarhini AA
Melanoma Res; 2015 Aug; 25(4):273-8. PubMed ID: 25933209
[TBL] [Abstract][Full Text] [Related]
38. Chromosomal rearrangements in uveal melanoma: Chromothripsis.
van Poppelen NM; Yavuzyigitoglu S; Smit KN; Vaarwater J; Eussen B; Brands T; Paridaens D; Kiliç E; de Klein A
Genes Chromosomes Cancer; 2018 Sep; 57(9):452-458. PubMed ID: 29726589
[TBL] [Abstract][Full Text] [Related]
39. Mutations of GNAQ, GNA11, SF3B1, EIF1AX, PLCB4 and CYSLTR in Uveal Melanoma in Chinese Patients.
Hou C; Xiao L; Ren X; Tang F; Guo B; Zeng W; Liang C; Yan N
Ophthalmic Res; 2020; 63(3):358-368. PubMed ID: 31614358
[TBL] [Abstract][Full Text] [Related]
40. Cherry Angiomas-Further Expanding the Phenotype With Somatic GNAQ and GNA11 Mutations.
Siegel DH
JAMA Dermatol; 2019 Feb; 155(2):148-149. PubMed ID: 30601884
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]